National survey on management of weight reduction in PCOS women in the United Kingdom

被引:11
作者
Sharma, Aarti [1 ]
Walker, Dawn-Marie [2 ]
Atiomo, William [3 ]
机构
[1] Univ Nottingham Hosp, Dept Obstet & Gynaecol, Nottingham NG5 1PB, England
[2] Univ Nottingham, Res Design Serv E Midlands NDL, Nottingham NG7 2RD, England
[3] Univ Nottingham, Queens Med Ctr, Div Human Dev, Sch Clin Sci, Nottingham NG7 2UH, England
关键词
Survey; Polycystic ovaries; Weight management; Guidelines; POLYCYSTIC-OVARY-SYNDROME; LIFE-STYLE MODIFICATION; INSULIN-RESISTANCE; SURGICAL-TREATMENT; BARIATRIC SURGERY; OBESE-PATIENTS; DOUBLE-BLIND; METFORMIN; ORLISTAT; METAANALYSIS;
D O I
10.1016/j.ejogrb.2010.07.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To identify the most commonly used methods for weight reduction in women with polycystic ovarian syndrome (PCOS) utilized by obstetricians and gynaecologists in the United Kingdom (UK). Study design: Permission was sought from the Royal College of Obstetricians and Gynaecologists (RCOG) to conduct an electronic survey of all consultants practising in the UK. The questionnaire was anonymous and an electronic link was sent via email to the 1140 consultants whose details were provided by the RCOG. A 27-item questionnaire was developed. The variables evaluated were first-line methods of weight reduction used, proportion of women with PCOS seen that were obese, whether the patients had tried other weight reduction methods before seeking help, the optimal dietary advice and optimal composition, the optimal duration and frequency of exercise suggested, BMI used for suggesting weight loss, percentage of women in whom weight loss worked, length of time allowed prior to suggesting another method, methods considered most effective by patients, use of metformin for weight loss, criteria used for prescribing metformin, first-line anti-obesity drugs preferred if any, second- and third-line methods used, referral to other specialists and criteria for referral for bariatric surgery. Responses were categorical and are reported as proportions. Results: One hundred and seven (9.4%) consultants responded to the questionnaire. One hundred and four (97%) provided advice on diet and 101(94%) advice on exercise as their first-line strategy for weight management. Fifty-one (47.7%) stated that they provided specific information on an optimal dietary intake, 53 (49.9%) on the optimal dietary composition and 61 (57%) on the optimal duration and frequency of exercise per week. The commonest second-line methods used were anti-obesity drugs and metformin and the most popular third-line management options were anti-obesity drugs and bariatric surgery. Conclusions: The results suggest that the information provided to women with PCOS on weight management is variable, and highlight the need for specific guidelines and further research on weight management in women with this condition. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 24 条
[1]  
[Anonymous], 2006, OB PREV ID ASS MAN O
[2]   Bariatric surgery: A systematic review and meta-analysis [J].
Buchwald, H ;
Avidor, Y ;
Braunwald, E ;
Jensen, MD ;
Pories, W ;
Fahrbach, K ;
Schoelles, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1724-1737
[3]   Surgical treatment of obesity [J].
Bult, Marielle J. F. ;
van Dalen, Thijs ;
Muller, Alex F. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (02) :135-145
[4]   Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome [J].
Cho, L. W. ;
Kilpatrick, E. S. ;
Keevil, B. G. ;
Coady, A. M. ;
Atkin, S. L. .
CLINICAL ENDOCRINOLOGY, 2009, 70 (02) :233-237
[5]   Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet [J].
Crosignani, PG ;
Colombo, M ;
Vegetti, W ;
Somigliana, E ;
Gessati, A ;
Ragni, G .
HUMAN REPRODUCTION, 2003, 18 (09) :1928-1932
[6]   The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery [J].
Escobar-Morreale, HF ;
Botella-Carretero, JI ;
Alvarez-Blasco, F ;
Sancho, J ;
San Millán, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6364-6369
[7]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47
[8]   Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome [J].
Hart, R ;
Hickey, M ;
Franks, S .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) :671-683
[9]   The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials [J].
Hoeger, Kathleen ;
Davidson, Kristen ;
Kochman, Lynda ;
Cherry, Tracy ;
Kopin, Laurie ;
Guzick, David S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (11) :4299-4306
[10]   A randomized, 48-week, placebocontrolled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study [J].
Hoeger, KM ;
Kochman, L ;
Wixom, N ;
Craig, K ;
Miller, RK ;
Guzick, DS .
FERTILITY AND STERILITY, 2004, 82 (02) :421-429